Combining kinase inhibitors for optimallyco-targetingcancer and drug escape by exploitation of drug target promiscuities

导出原文传递

翻译打印收藏纠错

作者： Chen, Shangying ^[1] ; Yang, Sheng Yong ^[2] ; Zeng, Xian ^[3] ; Zhu, Feng ^[4] ; Tan, Ying ^[5] ; Jiang, Yu Yang ; Chen, Yu Zong

作者单位： Tsinghua Univ, Shenzhen Kivita Innovat Drug Discovery Inst, Tsinghua Shenzhen Int Grad Sch, State ^[1] Fudan Univ, Sch Pharm, Dept Biol Med, Shanghai, Peoples R China ^[2] Sichuan Univ, West China Sch Med, West China Hosp, Mol Med Res Ctr,State Key Lab Biotherapy ^[3] Natl Univ Singapore, Dept Pharm, Bioinformat & Drug Design Grp, Singapore 117543, Singapore ^[4] Zhejiang Univ, Coll Pharmaceut Sci, Drug Res & Bioinformat Grp, Hangzhou, Peoples R China ^[5]

关键词 anticancer drug combinations drug resistance

发布时间 2021-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Drug Development Research

2021年82卷1期

133-142页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Combining kinase inhibitors for optimallyco-targetingcancer and drug escape by exploitation of drug target promiscuities

Drug Development Research

相似文献

Drug Development Research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combining kinase inhibitors for optimallyco-targetingcancer and drug escape by exploitation of drug target promiscuities

Drug Development Research

相似文献

Drug Development Research

相关期刊

检索历史清除